e-learning
resources
Paris 2018
Tuesday, 18.09.2018
Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The expression of selected biomarkers at the systemic and local level in patients with COPD
P. Nejman-Gryz (Warsaw, Poland), M. Paplinska-Goryca (Warsaw, Poland), M. Proboszcz (Warsaw, Poland), K. Górska (Warsaw, Poland), M. Maskey-Warzechowska (Warsaw, Poland), R. Krenke (Warsaw, Poland)
Source:
International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Session:
Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Session type:
Thematic Poster
Number:
4455
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Nejman-Gryz (Warsaw, Poland), M. Paplinska-Goryca (Warsaw, Poland), M. Proboszcz (Warsaw, Poland), K. Górska (Warsaw, Poland), M. Maskey-Warzechowska (Warsaw, Poland), R. Krenke (Warsaw, Poland). The expression of selected biomarkers at the systemic and local level in patients with COPD. 4455
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Related content which might interest you:
Differences in biomarkers of systemic inflammation in two phenotypes of COPD patients
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Some local markers indices of saliva inflammation in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 62s
Year: 2004
The association between lung function and exacerbation frequency in patients with COPD, results from a systemic review
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity
Source: Annual Congress 2013 –COPD: markers and inflammation
Year: 2013
Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007
Cytokine regulation of local and systemic inflammation in COPD patients
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
VEGF serum levels in COPD patients without pulmonary hypertension – a case control study
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
The interaction between leptin and inflammatory markers in induced sputum in patients with moderate COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002
The relationship between comorbidities and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011
Temporal profile and clinical utility of inflammatory markers in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Structural remodelling in COPD
Year: 2008
Expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in patients with different severity of asthma and BHR level
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Different pattern of systemic and local inflammation in patients with exacerbation of COPD with different body composition
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Are there gender differences of systemic inflammatory state in COPD patients?
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
Proteomic analysis of plasma from COPD patients and smoking control subjects
Source: Annual Congress 2007 - Novel therapeutic targets and disease markers in pulmonary pathology
Year: 2007
C-reactive protein levels and clinically important predictive outcomes in stable COPD patients
Source: Eur Respir J 2006; 27: 902-907
Year: 2006
Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients.
Source: Virtual Congress 2020 – COPD phenotypes
Year: 2020
Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
The increased production level of 15 cytokines associated with tuberculosis severity and patients’ responsiveness to therapy.
Source: International Congress 2019 – Tuberculosis: from basic science to patient care
Year: 2019
Serum TGF-β level in patients with different stages of stable COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept